PMI Stock: Price, Forecast, Financials & AI Analysis

Loading...

Loading chart...

High

1.060

Open

0.987

VWAP

1.02

Vol

118.43K

Mkt Cap

72.96M

Low

0.987

Amount

121.08K

EV/EBITDA(TTM)

--

Total Shares

73.70M

EV

70.26M

EV/OCF(TTM)

--

P/S(TTM)

15.09

Picard Medical, Inc. is a holding company that owns a 100% interest in SynCardia Systems, LLC (SynCardia). SynCardia is a medical technology company that manufactures and sells the only United States Food and Drug Administration (FDA) and Health Canada-approved implantable total artificial heart (SynCardia TAH). The SynCardia TAH is a biventricular replacement device that consists of the SynCardia TAH implant, an external pneumatic driver that delivers precisely calibrated pulses of air to drive the implant, and drivelines that connect the driver to the implant. The SynCardia TAH implant is a system that consists of two independent artificial ventricles which are powered by an external pneumatic driver. Each artificial ventricle is made of a semi-rigid polyurethane housing and a rigid polyurethane base, with a four-layer flexible polyurethane diaphragm separating the blood chamber from the air chamber.

Show More

Events Timeline

(ET)

2026-03-19

08:30:00

Picard Medical Highlights Successful Heart Transplant Case Using Total Artificial Heart

2026-02-12 (ET)

2026-02-12

08:50:00

Picard Medical Announces UCSF's First Heart Transplant Success

2026-01-12 (ET)

2026-01-12

11:10:00

Company Not Selling Common Stock, No Proceeds Received

2026-01-12

09:10:00

Picard Medical Partners with Hydrix to Develop Next-Gen Artificial Heart Technology

2026-01-06 (ET)

2026-01-06

08:10:00

Picard Medical Introduces New Design Component for SynCardia Total Artificial Heart

2025-12-02 (ET)

2025-12-02

07:30:00

PMI Confirms 2025 Full-Year Diluted EPS Forecast of $7.39 to $7.49

News

seekingalpha

12:12 PMseekingalpha

PinnedPicard Medical Reports 12.5% Revenue Growth for FY 2025

PRnewswire

13:55 PMPRnewswire

Class Action Lawsuit Filed Against Picard Medical, Inc.

Globenewswire

03-24Globenewswire

Class Action Lawsuit Filed Against Picard Medical, Inc.

Globenewswire

03-24Globenewswire

Class Action Notice for Picard Medical Securities Purchasers

Globenewswire

03-24Globenewswire

Reminder of Class Action Lawsuit for Picard Medical Investors

Globenewswire

03-24Globenewswire

Faruqi & Faruqi Investigates Securities Fraud at Picard Medical

Valuation Metrics

The current forward P/E ratio for Picard Medical Inc (PMI.A) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess Picard Medical Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

dotted line Image

N/A

5Y Average PE

0.00

Current PE

0.00

Overvalued PE

0.00

Undervalued PE

0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

dotted line Image

N/A

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

0.00

Undervalued EV/EBITDA

0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

dotted line Image

N/A

5Y Average PS

0.00

Current PS

0.00

Overvalued PS

0.00

Undervalued PS

0.00

Financials

AI Analysis

Annual

Quarterly

Whales Holding PMI

Trading Trends

People Also Watch

Frequently Asked Questions

What is Picard Medical Inc (PMI) stock price today?

The current price of PMI is 1.02 USD — it has increased 3.03

What is Picard Medical Inc (PMI)'s business?

Picard Medical, Inc. is a holding company that owns a 100% interest in SynCardia Systems, LLC (SynCardia). SynCardia is a medical technology company that manufactures and sells the only United States Food and Drug Administration (FDA) and Health Canada-approved implantable total artificial heart (SynCardia TAH). The SynCardia TAH is a biventricular replacement device that consists of the SynCardia TAH implant, an external pneumatic driver that delivers precisely calibrated pulses of air to drive the implant, and drivelines that connect the driver to the implant. The SynCardia TAH implant is a system that consists of two independent artificial ventricles which are powered by an external pneumatic driver. Each artificial ventricle is made of a semi-rigid polyurethane housing and a rigid polyurethane base, with a four-layer flexible polyurethane diaphragm separating the blood chamber from the air chamber.

What is the price predicton of PMI Stock?

Wall Street analysts forecast PMI stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for PMI is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Picard Medical Inc (PMI)'s revenue for the last quarter?

Picard Medical Inc revenue for the last quarter amounts to 1.19M USD, increased 34.73

What is Picard Medical Inc (PMI)'s earnings per share (EPS) for the last quarter?

Picard Medical Inc. EPS for the last quarter amounts to -0.14 USD, increased 40.00

How many employees does Picard Medical Inc (PMI). have?

Picard Medical Inc (PMI) has 75 emplpoyees as of March 25 2026.

What is Picard Medical Inc (PMI) market cap?

Today PMI has the market capitalization of 72.96M USD.